Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: A retrospective MITO group study.

Sabrina Chiara Cecere, Lucia Musacchio, Michele Bartoletti, Vanda Salutari, Laura Arenare, Domenica Lorusso, Graziana Ronzino, Rossella Lauria, Gennaro Cormio, Emanuele Naglieri, Paolo Scollo, Claudia Marchetti, Francesco Raspagliesi, Stefano Greggi, Saverio Cinieri, Alice Bergamini, Michele Orditura, Giorgio Valabrega, Giovanni Scambia, Fabio MartinelliElisabetta De Matteis, Cinzia Cardalesi, Vera Loizzi, Giorgia Perniola, Claudia Carella, Giuseppa Scandurra, Gaia Giannone, Sandro Pignata

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: A retrospective MITO group study.'. Together they form a unique fingerprint.

Medicine & Life Sciences